Physician profile
James Frederick Weber Pike
NPI 1437725959
$7,010.32
in general payments reported to CMS, 2019-2025
22 companies · $2,125 in 2025
The $2,125 reported for 2025 was more than what 96% of Pediatric Urology providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $778 · 2023: $1,368 · 2024: $2,515 · 2025: $2,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,934 · Travel and Lodging: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,934.15 |
| Travel and Lodging | $1,073.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,012.04 | 2023-2025 | Titan, Speedicath |
| Boston Scientific Corporation | $1,368.03 | 2021-2024 | Ams 700, Xpeeda Dsl Fiber, Solyx Sis System |
| Teleflex LLC | $1,091.97 | 2023-2025 | Urolift, Barrigel, Deflux |
| Procept Biorobotics Corporation | $437.69 | 2023-2025 | Aquabeam Robotic System |
| Axonics, INC. | $264.52 | 2022-2024 | Axonics |
| Olympus America INC. | $252.19 | 2023-2024 | Itind System, Olympus |
| Merck Sharp & Dohme LLC | $160.15 | 2021-2024 | Lynparza, Keytruda |
| Conmed Corporation | $141.19 | 2023 | Airseal |
| Calyxo, INC. | $139.64 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $135.19 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $125.00 | 2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $119.92 | 2025 | |
| Angiodynamics, INC. | $115.22 | 2025 | Nanoknife |
| Janssen Scientific Affairs, LLC | $113.57 | 2024-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $110.25 | 2025 | Provenge |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $109.79 | 2024 | Oxlumo |
| Palette Life Sciences, INC. | $105.31 | 2022 | |
| Janssen Biotech, INC. | $83.10 | 2021 | |
| Blue Earth Diagnostics | $41.62 | 2023 | |
| Innovation Technologies INC | $36.32 | 2024 | Irrisept |
| 180 Medical, INC. | $33.31 | 2023 | Gentlecath Glide |
| Astrazeneca Pharmaceuticals Lp | $14.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Pike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.